The North America patient support technology market size was estimated at USD 578.9 million in 2022 and is expected to surpass around USD 1,658.61 million by 2032 and poised to grow at a compound annual growth rate (CAGR) of 11.1% during the forecast period 2023 to 2032.
Key Takeaways:
The increasing demand for comprehensive patient-centric engagement solutions in pharmaceutical firms is expected to drive market growth. For instance, in a published case study, Deloitte highlighted its ConvergeHEALTH platform, which seamlessly connects regional patient support programs with crucial supply chain cost metrics. This study showcases that when used by a global pharmaceutical firm, the platform substantially enhanced patient engagement, leading to a 50% increase in patient interactions. This, in turn, empowered educators and agents to foster lasting relationships with patients.
Furthermore, S3 Connected Health played a key role in creating and implementing the mobile and web-based system for Merck's digital patient support program called "MSdialog." This initiative aimed to simultaneously monitor medication adherence and collect patient-reported outcomes on a large scale. The results were highly positive, with 77% of patients expressing high satisfaction levels (either very satisfied or extremely satisfied) with their experience in the digital patient support program after six weeks.
The advancements in AI-enabled technologies are anticipated to fuel market expansion. For instance, AllazoHealth's AI-powered Patient Support Program (PSP) has remarkably improved medication adherence. In a published case study, patients enrolled in this program adhered 4.6 times longer compared to those without AI support.
Moreover, the adoption of chatbots in Patient Support Programs (PSPs) has surged significantly, notably accelerated by the COVID-19 pandemic. Chatbots have emerged as valuable tools for addressing medication-related inquiries and potential side effects and offering reassurance to patients. These chatbots are equipped with personalized profiles, enabling tailored interactions that assist patients in adhering to their treatment regimens. For example, Clinikly.ai, an AI-powered chatbot accessible via web and smartphone apps, employs a virtual nurse to provide remote patient support and plays a crucial role in delivering personalized information, thereby enhancing the overall patient experience.
North America Patient Support Technology Market Report Scope
Report Attribute | Details |
Market Size in 2023 | USD 643.16 Million |
Market Size by 2032 | USD 1,658.61 Million |
Growth Rate From 2023 to 2032 | CAGR of 11.1% |
Base Year | 2022 |
Forecast Period | 2023 to 2032 |
Segments Covered | Type, country |
Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Key Companies Profiled | Deloitte; Accenture; McKesson Corporation; Cardinal Health; DataRiver S.r.l; Medisafe; Inizio Engage; AssistRx |
North America Patient Support Technology Market Dynamics
Drivers
Restraints
Opportunities
Challenges
Segments Insights:
Type Insights
Based on the type, the market is segmented into standalone and integrated segments. The integrated segment dominated the market in 2022 with a revenue share of over 65.9%. The segment is also expected to grow at the fastest rate of 11.4%. Increasing focus on patient-centered care, technological advancements, and the need for streamlined & efficient healthcare processes is driving the segment growth. These solutions enable the providers to effectively engage with patients and provide tailored treatment plans.
For instance, in July 2023, Inizio Engage launched Patient Access Services, a comprehensive suite of patient support services aimed at improving access to and adherence to specialty therapies. This initiative leverages the Trak360 platform, which incorporates advanced capabilities for seamlessly and securely connecting patient engagements. These enhancements simplify the complex aspects of patients' treatment journeys, ensuring a fully integrated and cohesive experience from the point of diagnosis through ongoing patient engagement and support.
Country Insights
The demand for patient support technology in North America is rising, driven by a growing emphasis on patient-centered healthcare, ongoing digital transformation in the healthcare industry, and the shift from fee-for-service to value-based care models. Healthcare providers in North America are increasingly focused on managing the health of entire populations, further fueling market growth. In 2022, the U.S. dominated the North American market due to the increased presence of healthcare organizations seeking structured data and automation solutions.
Key industry players are also taking strategic steps to expand their market reach. For instance, in June 2023, Mural Health and ClinOne partnered to optimize the patient experience while reducing the burden on healthcare sites. This partnership integrates Mural Link, a next-generation patient payments and participant management platform, into ClinOne's patient support, streamlining site-level operations and trial management technology and enhancing the participant journey.
Canada is anticipated to experience the fastest CAGR of 8.7% during the forecast period. This growth is driven by technological advancements, increasing number of hospitals, and subsequent demand for integrated healthcare systems to improve workflow efficiency.
Key Companies & Market Share Insights
Key market players are implementing various strategic initiatives to enhance their market presence, including new product launches, collaborations, and geographical expansions.
For instance, in June 2023, AssistRx, a provider of advanced therapy initiation and patient solutions, entered the patient support technology market with the introduction of Advanced Gateway. This offering represents the industry's first single API integration designed to quickly deploy comprehensive, technology-driven self-service solutions for both patients and healthcare providers (HCPs). Advanced Gateway consolidates multiple AssistRx technology solutions into a single integration across life sciences organizations' access channels, offering flexibility to include human intervention when dealing with complex cases. Some prominent players in the North America patient support technology market include:
Segments Covered in the Report
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2020 to 2032. For this study, Nova one advisor, Inc. has segmented the North America Patient Support Technology market.
By Type
By Regional
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Product Segment
1.1.1.2. Method Segment
1.1.1.3. End-use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objective
1.4.1. Objective 1
1.4.2. Objective 2
1.4.3. Objective 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Nova one advisor’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis:
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.4.1. Technological Advancements
3.4.2. Rising initiatives by Organization
3.5. Market Restraint Analysis
3.5.1. Data Security and Privacy Concerns
3.6. Product Analysis Tools
3.6.1. Porter’s Five Forces Analysis
3.6.2. PESTEL Analysis
3.7. COVID-19 Impact Analysis
3.8. Case study - Patient Support Technology
3.8.1. Case Study - 1
3.8.2. Case Study - 2
3.8.3. Case Study - 3
3.8.4. Case Study - 4
3.8.5. Case Study - 5
Chapter 4. Type Business Analysis
4.1. North America Patient Support Technology Market: Type Movement Analysis
4.2. Standalone
4.2.1. Standalone Market, 2020 - 2032
4.3. Integrated
4.3.1. Integrated Market, 2020 - 2032
Chapter 5. Country Business Analysis
5.1. North America Patient Support Technology Market Share By Country, 2023 - 2032
5.2. North America
5.2.1. SWOT Analysis
5.2.2. North America Patient Support Technology Market, 2020 - 2032
5.2.3. U.S.
5.2.3.1. Key Country Dynamics
5.2.3.2. Competitive Scenario
5.2.3.3. Regulatory Framework
5.2.3.4. U.S. Patient Support Technology Market, 2020 - 2032
5.2.4. Canada
5.2.4.1. Key Country Dynamics
5.2.4.2. Competitive Scenario
5.2.4.3. Regulatory Framework
5.2.4.4. Canada Patient Support Technology Market, 2020 - 2032
Chapter 6. Competitive Landscape
6.1. Company Categorization
6.2. Strategy Mapping
6.3. Company Market Share Analysis, 2022
6.4. Company Profiles
6.4.1. Deloitte
6.4.1.1. Overview
6.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.1.3. Product Benchmarking
6.4.1.4. Strategic Initiatives
6.4.2. Accenture
6.4.2.1. Overview
6.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.2.3. Product Benchmarking
6.4.2.4. Strategic Initiatives
6.4.3. McKesson Corporation
6.4.3.1. Overview
6.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.3.3. Product Benchmarking
6.4.3.4. Strategic Initiatives
6.4.4. Cardinal Health
6.4.4.1. Overview
6.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.4.3. Product Benchmarking
6.4.4.4. Strategic Initiatives
6.4.5. Inizio Engage
6.4.5.1. Overview
6.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.5.3. Product Benchmarking
6.4.5.4. Strategic Initiatives
6.4.6. DataRiver S.r.l
6.4.6.1. Overview
6.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.6.3. Product Benchmarking
6.4.6.4. Strategic Initiatives
6.4.7. AssistRx
6.4.7.1. Overview
6.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.7.3. Product Benchmarking
6.4.7.4. Strategic Initiatives
6.4.8. Medisafe
6.4.8.1. Overview
6.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.8.3. Product Benchmarking
6.4.8.4. Strategic Initiatives